Literature DB >> 24771058

Control of blood pressure in hypertensive neurological emergencies.

Lisa Manning1, Thompson G Robinson, Craig S Anderson.   

Abstract

Neurological hypertensive emergencies cause significant morbidity and mortality. Most occur in the setting of ischaemic stroke, spontaneous intracerebral hemorrhage (ICH), or subarachnoid hemorrhage (SAH), but other causes relate to hypertensive encephalopathy and reversible cerebral vasoconstriction syndrome (RCVS). Prompt and controlled reduction of blood pressure (BP) is necessary, although there remains uncertainty as to the optimal rate of decline and ideal antihypertensive agent. There is probably no single treatment strategy that covers all neurological hypertensive emergencies. Prompt diagnosis of the underlying disorder, recognition of its severity, and appropriate targeted treatment are required. Lack of comparative-effectiveness data leaves clinicians with limited evidence-based guidance in management, although significant developments have occurred recently in the field. In this article, we review the management of specific neurological hypertensive emergencies, with particular emphasis on recent evidence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24771058     DOI: 10.1007/s11906-014-0436-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  93 in total

Review 1.  The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Guidelines for cerebral perfusion pressure.

Authors: 
Journal:  J Neurotrauma       Date:  2000 Jun-Jul       Impact factor: 5.269

2.  The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients.

Authors:  Solomon Aronson; Cornelius M Dyke; Kevin A Stierer; Jerrold H Levy; Albert T Cheung; Philip D Lumb; Dean J Kereiakes; Mark F Newman
Journal:  Anesth Analg       Date:  2008-10       Impact factor: 5.108

Review 3.  Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage.

Authors:  Karol P Budohoski; Marek Czosnyka; Peter J Kirkpatrick; Peter Smielewski; Luzius A Steiner; John D Pickard
Journal:  Nat Rev Neurol       Date:  2013-02-19       Impact factor: 42.937

Review 4.  Urapidil, a dual-acting antihypertensive agent: Current usage considerations.

Authors:  Jan Buch
Journal:  Adv Ther       Date:  2010-06-28       Impact factor: 3.845

Review 5.  Vasoactive drugs for acute stroke.

Authors: 
Journal:  Cochrane Database Syst Rev       Date:  2000

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial.

Authors:  Carmelo Graffagnino; Sergio Bergese; James Love; Dietmar Schneider; Christos Lazaridis; Marc LaPointe; Kiwon Lee; Gwendolyn Lynch; Ming-yi Hu; Gregory C Williams
Journal:  Cerebrovasc Dis       Date:  2013-10-12       Impact factor: 2.762

8.  Low dose beta blockade in acute stroke ("BEST" trial): an evaluation.

Authors:  D H Barer; J M Cruickshank; S B Ebrahim; J R Mitchell
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-12

9.  The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.

Authors:  Else Charlotte Sandset; Philip M W Bath; Gudrun Boysen; Dalius Jatuzis; Janika Kõrv; Stephan Lüders; Gordon D Murray; Przemyslaw S Richter; Risto O Roine; Andreas Terént; Vincent Thijs; Eivind Berge
Journal:  Lancet       Date:  2011-02-26       Impact factor: 79.321

Review 10.  High blood pressure in acute stroke and subsequent outcome: a systematic review.

Authors:  Mark Willmot; Jo Leonardi-Bee; Philip M W Bath
Journal:  Hypertension       Date:  2003-12-08       Impact factor: 10.190

View more
  6 in total

1.  Treatment of hypertensive emergencies.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-05

Review 2.  The Management of Hypertensive Emergencies-Is There a "Magical" Prescription for All?

Authors:  Ana-Maria Balahura; Ștefan-Ionuț Moroi; Alexandru Scafa-Udrişte; Emma Weiss; Cristina Japie; Daniela Bartoş; Elisabeta Bădilă
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

Review 3.  Clevidipine: a review of its use for managing blood pressure in perioperative and intensive care settings.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

4.  Risk of Stroke After the International Classification of Diseases-Ninth Revision Discharge Code Diagnosis of Hypertensive Encephalopathy.

Authors:  Michael P Lerario; Alexander E Merkler; Gino Gialdini; Neal S Parikh; Babak B Navi; Hooman Kamel
Journal:  Stroke       Date:  2016-01-07       Impact factor: 7.914

Review 5.  New Developments in Hypertensive Encephalopathy.

Authors:  Joseph B Miller; Kushak Suchdev; Namita Jayaprakash; Daniel Hrabec; Aditya Sood; Snigdha Sharma; Phillip D Levy
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

6.  Functional Outcome Measures of Recombinant Tissue Plasminogen Activator-Treated Stroke Patients in the Telestroke Technology.

Authors:  Jordan Gainey; Leanne Brecthtel; Brice Blum; Aaliyah Keels; Lee Madeline; Ervin Lowther; Thomas Nathaniel
Journal:  J Exp Neurosci       Date:  2018-09-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.